Designer Protein Therapy Enters Human Trials, Stuns Neuroscientists
A novel chemogenetic approach using engineered proteins to control brain cells shows early promise in human trials, raising new possibilities for neurological disorders.

Five shifts. Five minutes. No noise.
No spam. Unsubscribe anytime. Powered by Beehiiv.

Most AI security training focuses on prompt injection, but overlooks the fundamental risk of loading malicious code via model weights.

Stop refreshing Twitter for AI model releases. The real news is on pricing pages and API docs.

A new app built for the Google Cloud Run AI Challenge aims to turn journaling into actionable insights.
A novel chemogenetic approach using engineered proteins to control brain cells shows early promise in human trials, raising new possibilities for neurological disorders.

A developer explains how backtracking, inspired by a 'dream within a dream' interview question, provides a principled approach to solving complex problems like Sudoku.
Researchers face a tight turnaround as NeurIPS 2026 author notifications arrive just one day before the ICLR 2027 paper submission deadline.
Early comparisons of AI-generated reviews for top ML papers reveal significant differences from human feedback.
The ambition to replicate human cognition in silicon faces immense hurdles, from understanding consciousness to the sheer complexity of neural architecture.
AI products often blur the line between tool and platform as users build workflows and integrations around them.

A novel compiler translates Doom's rendering logic into transformer weights, generating pixel commands from scene data.

As AI agents gain autonomy, the question of responsibility for their errors moves from the technical to the legal and ethical.

Developer builds Ava, an AI English tutor that listens, remembers, and converses naturally.

Retrieval-Augmented Generation lets AI answer questions using your documents, not just its training data.